Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.

Postgraduate medicine

Volumn 125, Issue 3, 2013, Pages 112-126

  Nadeau, Daniel A ^a  

^a York Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; INSULIN; METFORMIN;

DIET THERAPY; DRUG POTENTIATION; HUMAN; KINESIOTHERAPY; LOW CALORY DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK REDUCTION;

DIABETES MELLITUS, TYPE 2; DIET, REDUCING; EXERCISE THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; RECEPTORS, GLUCAGON; RISK REDUCTION BEHAVIOR;

EID: 84882261930     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.05.2666     Document Type: Review

References (0)